Dianthus Therapeutics Inc. (DNTH) — Financial Flexibility Index
Dianthus Therapeutics Inc. (DNTH) has a Financial Flexibility Index of -1.18x as of June 2026. Free cash flow of $-48.80 Million (operating CF $-48.98 Million minus capex $181.00K) represents -1% of total liabilities ($41.25 Million). Check total reinvestment intensity of Dianthus Therapeutics Inc. to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Dianthus Therapeutics Inc. Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Dianthus Therapeutics Inc. across 10 annual periods. For the full cash flow conversion analysis, see Dianthus Therapeutics Inc. operating cash flow efficiency.
Annual Financial Flexibility Index for Dianthus Therapeutics Inc. (2016–2025)
Year-by-year free cash flow to debt coverage for Dianthus Therapeutics Inc.. Explore DNTH operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.43x | $-128.85 Million | $-129.06 Million | $37.52 Million | ▲ +5.3% |
| 2024 | -3.63x | $-78.08 Million | $-78.18 Million | $21.53 Million | ▼ -3.9% |
| 2023 | -3.49x | $-36.75 Million | $-36.86 Million | $10.54 Million | ▼ -14.0% |
| 2022 | -3.06x | $-28.93 Million | $-29.07 Million | $9.45 Million | ▲ +9.3% |
| 2021 | -3.38x | $-58.27 Million | $-59.53 Million | $17.26 Million | ▲ +6.0% |
| 2020 | -3.59x | $-63.62 Million | $-64.02 Million | $17.71 Million | ▼ -35.1% |
| 2019 | -2.66x | $-54.04 Million | $-57.10 Million | $20.32 Million | ▲ +9.3% |
| 2018 | -2.93x | $-34.21 Million | $-41.89 Million | $11.66 Million | ▲ +39.5% |
| 2017 | -4.84x | $-20.06 Million | $-22.26 Million | $4.14 Million | ▼ -74.4% |
| 2016 | -2.78x | $-6.39 Million | $-6.53 Million | $2.30 Million | — |